Prevention of bleeding in total hip and knee replacement: Contribution of combined route in tranexamic acid administration.

##plugins.themes.academic_pro.article.sidebar##

Published Feb 1, 2025
https://doi.org/10.62438/tunismed.v103i2.4991
Download
pdf
Vol. 103 No. 2 (2025): Tunis Med Feb 2025

##plugins.themes.academic_pro.article.main##

Eya Langar
Department of Anesthesiology and Critical Care Medicine, Mongi Slim Teaching Hospital, University of Tunis El Manar, Faculty of Medicine of Tunis,Tunis, Tunisia
Faten Haddad
Department of Anesthesiology and Critical Care Medicine, Mongi Slim Teaching Hospital, University of Tunis El Manar, Faculty of Medicine of Tunis,Tunis, Tunisia
Amani Ben Hadj Youssef
Department of Anesthesiology and Critical Care Medicine, Mongi Slim Teaching Hospital, University of Tunis El Manar, Faculty of Medicine of Tunis,Tunis, Tunisia
Emna Kammoun
Department of Anesthesiology and Critical Care Medicine, Mongi Slim Teaching Hospital, University of Tunis El Manar, Faculty of Medicine of Tunis,Tunis, Tunisia
Issam Saddem
Department of Anesthesiology and Critical Care Medicine, Mongi Slim Teaching Hospital, University of Tunis El Manar, Faculty of Medicine of Tunis,Tunis, Tunisia
Mhamed Sami Mebazaa
Department of Anesthesiology and Critical Care Medicine, Mongi Slim Teaching Hospital, University of Tunis El Manar, Faculty of Medicine of Tunis,Tunis, Tunisia

Abstract

Introduction: Tranexamic acid (TXA) has revolutionized perioperative blood management of total hip (THA) and knee arthroplasties (TKA). However, there is currently no consensus on the optimal administration route.


Aim: To compare the combined administration of TXA (intravenously (IV) and topically) versus IV alone on the reduction of postoperative bleeding in THA and TKA.


Methods: A nine-month double-blind randomized trial was conducted. Adult consenting patients scheduled for primary total hip arthroplasty (THA) or total knee arthroplasty (TKA) were included. The primary outcome measure was the decrease in hemoglobin levels 24 hours after surgery. They were randomized either to the IV group (51 patients) receiving 2 doses of 1 g of IV TXA 3 hours apart, or to the Combined group (50 patients) receiving 1 g of IV TXA and a topical dose of 1.5 g.


Results: The mean decrease in hemoglobin 24 hours after surgery was similar for both groups in THA (p=0.91) and TKA (p=0.19). There was no difference in perioperative transfusion rate between the two THA groups (p=0.6). In TKA, no perioperative transfusion was required. Total and measured blood losses were similar in both groups. Immediate and 3-month postoperative complications were similar.


Conclusion: Compared to IV TXA alone, the combined route does not reduce the risk of bleeding in prosthetic surgery

Keywords:

tranexamic acid, knee replacement, total hip replacement, bleeding, transfusion of red blood cells

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

References

  1. Maradit Kremers H, Larson DR, Crowson CS, Kremers WK, Washington RE, Steiner CA, et al. Prevalence of total hip and knee replacement in the United States. J Bone Joint Surg Am. 2015 Sep;97(17):1386-97.
  2. Putman S, Girier N, Girard J, Pasquier G, Migaud H, Chazard E. Épidémiologie des prothèses de hanche en France : analyse de la base nationale du PMSI de 2008 à 2014. Rev Chir Orthop Traumatol. Nov 2017;103 Suppl 7:90.
  3. Le Stum M, Gicquel T, Dardenne G, Le Goff Pronost M, Stindel E, Clavé A. Prothèses totale de genou en France : une croissance portée par les hommes entre 2009 et 2019. Projections à 2050. Rev Chir Orthop Traumatol [En ligne]. Nov 2022 [Consulté le 27 avr 2023]. Consultable à l’URL: https://www.sciencedirect.com/science/article/pii/S187705172200510X
  4. Donovan RL, Lostis E, Jones I, Whitehouse MR. Estimation of blood volume and blood loss in primary total hip and knee replacement: An analysis of formulae for perioperative calculations and their ability to predict length of stay and blood transfusion requirements. J Orthop. 2021 Mar 12;24:227-232. doi: 10.1016/j.jor.2021.03.004. PMID: 33814813; PMCID: PMC7995348.
  5. Mohib Y, Haroon Rashid R, Ali M, Zubairi AJ, Umer M. Does tranexamic acid reduce blood transfusion following surgery for inter-trochanteric fracture? A randomized control trial. J Pak Med Assoc. 2015 Nov;65 Suppl 3: p17-20.
  6. Fillingham YA, Ramkumar DB, Jevsevar DS, Yates AJ, Bini SA, Clarke HD, et al. Tranexamic acid in total joint arthroplasty: the endorsed clinical practice guides of the american association of hip and knee surgeons, american society of regional anesthesia and pain medicine, american academy of orthopaedic surgeons, hip society, and knee society. Reg Anesth Pain Med. 2019 Jan;44(1):7-11.
  7. De Maeyer EM, Dallman P, Gurney JM, Hallberg L, Sood SK, Srikantia SG, et al. Preventing and controlling iron deficiency anaemia through primary health care [En ligne]. Déc 1989 [Consulté le 27 avr 2023]; [61 pages]. Consultable à l’URL: https://apps.who.int/iris/bitstream/handle/10665/39849/9241542497_eng.pdf
  8. Gross JB. Estimating allowable blood loss: corrected for dilution. Anesthesiology. 1983 Mar;58(3):277-80.
  9. Triffault Fillit C, Ferry T, Laurent F, Pradat P, Dupieux C, Conrad A, et al. Microbiologic epidemiology depending on time to occurrence of prosthetic joint infection: a prospective cohort study. Clin Microbiol Infect. 2019 Mar;25(3):353-8.
  10. Chalmers BP, Mishu M, Cushner FD, Sculco PK, Nguyen J, Westrich GH. Is there a synergistic effect of topical plus intravenous tranexamic acid versus intravenous administration alone on blood loss and transfusions in primary total hip and knee arthroplasties? Arthroplast Today. 2021 Feb;7:194-9.
  11. Bonhomme F. Le saignement au bloc opératoire [En ligne]. Oct 2014 [Consulté le 27 avr 2023]; [12 pages]. Consultable à l’URL: https://sfar.org/wp-content/uploads/2014/04/27_Bonhomme.pdf
  12. Katsumata S, Nagashima M, Kato K, Tachihara A, Wauke K, Saito S, et al. Changes in coagulation-fibrinolysis marker and neutrophil elastase following the use of tourniquet during total knee arthroplasty and the influence of neutrophil elastase on thromboembolism. Acta Anaesthesiol Scand. 2005 Apr;49(4):510-6.
  13. Draxler DF, Medcalf RL. The fibrinolytic system more than fibrinolysis? Transfus Med Rev. 2015 Apr;29(2):102-9.
  14. Poeran J, Chan JJ, Zubizarreta N, Mazumdar M, Galatz LM, Moucha CS. Safety of Tranexamic Acid in Hip and Knee Arthroplasty in High-risk Patients. Anesthesiology. 1 juill 2021;135(1):57‑68.
  15. Sun Q, Li J, Chen J, Zheng C, Liu C, Jia Y. Comparison of intravenous, topical or combined routes of tranexamic acid administration in patients undergoing total knee and hip arthroplasty: a meta-analysis of randomised controlled trials. BMJ Open. 2019 Jan;9(1):e024350.
  16. Gilbody J, Dhotar HS, Perruccio AV, Davey JR. Topical tranexamic acid reduces transfusion rates in total hip and knee arthroplasty. J Arthroplasty. 2014 Apr;29(4):681-4.
  17. Dai L, Bevan D, Rangarajan S, Sørensen B, Mitchell M. Stabilization of fibrin clots by activated prothrombin complex concentrate and tranexamic acid in FVIII inhibitor plasma. Haemophilia. 2011 Sep;17(5):944-8. 62. Wei W, Dang S, Duan D, Wei L. Comparison of intravenous and topical tranexamic acid in total knee arthroplasty. BMC Musculoskelet Disord. 2018 Jun;19(1):191.
  18. Wei W, Dang S, Duan D, Wei L. Comparison of intravenous and topical tranexamic acid in total knee arthroplasty. BMC Musculoskelet Disord. 2018 Jun;19(1):191.
  19. Guerreiro JF, Badaro BS, Balbino JM, Danieli MV, Queiroz AO, Cataneo DC. Application of tranexamic acid in total knee arthroplasty prospective randomized trial. Open Orthop J. 2017 Aug;11:1049-57.
  20. Wurtz JW, Wurtz LD, Ziemba Davis M, Deckard ER, Meneghini RM. Topical tranexamic acid increases early postoperative pain after total hip arthroplasty. J Arthroplasty. 2020 Jun;35(6):219-25.
  21. Loomis CW, Khandwala H, Osmond G, Hefferan MP. Coadministration of intrathecal strychnine and bicuculline effects synergistic allodynia in the rat: an isobolographic analysis. J Pharmacol Exp Ther. 2001 Mar;296(3):756-61.
  22. Onaka M, Minami T, Nishihara I, Ito S. Involvement of glutamate receptors in strychnine- and bicuculline-induced allodynia in conscious mice. Anesthesiology. 1996 May;84(5):1215-22.
  23. McLean M, McCall K, Smith IM, Blyth M, Kitson SM, Crowe LN, et al. Tranexamic acid toxicity in human periarticular tissues. Bone Joint Res. 2019 Feb;8(1):11-8.
  24. Fraval A, Effeney P, Fiddelaers L, Smith B, Towell B, Tran P. OBTAIN A: outcome benefits of tranexamic acid in hip arthroplasty. A randomized double-blinded controlled trial. J Arthroplasty. 2017 May;32(5):1516-9.
  25. Remérand F, Cotten M, N’Guessan YF, Couvret C, Rosset P, Favard L, et al. Tranexamic acid decreases risk of haematomas but not pain after hip arthroplasty. Orthop Traumatol Surg Res. 2013 Oct;99(6):667-73.